Home Cart 0 Sign in  
X

[ CAS No. 139755-99-0 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 139755-99-0
Chemical Structure| 139755-99-0
Chemical Structure| 139755-99-0
Structure of 139755-99-0 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 139755-99-0 ]

Related Doc. of [ 139755-99-0 ]

Alternatived Products of [ 139755-99-0 ]

Product Details of [ 139755-99-0 ]

CAS No. :139755-99-0 MDL No. :MFCD02169703
Formula : C8H12N2O2 Boiling Point : -
Linear Structure Formula :- InChI Key :KOABFSONXOOIIH-UHFFFAOYSA-N
M.W : 168.19 Pubchem ID :587797
Synonyms :

Calculated chemistry of [ 139755-99-0 ]

Physicochemical Properties

Num. heavy atoms : 12
Num. arom. heavy atoms : 5
Fraction Csp3 : 0.5
Num. rotatable bonds : 3
Num. H-bond acceptors : 3.0
Num. H-bond donors : 1.0
Molar Refractivity : 45.03
TPSA : 55.12 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.42 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.58
Log Po/w (XLOGP3) : 1.28
Log Po/w (WLOGP) : 1.07
Log Po/w (MLOGP) : 0.67
Log Po/w (SILICOS-IT) : 0.8
Consensus Log Po/w : 1.08

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.56

Water Solubility

Log S (ESOL) : -1.8
Solubility : 2.67 mg/ml ; 0.0159 mol/l
Class : Very soluble
Log S (Ali) : -2.04
Solubility : 1.54 mg/ml ; 0.00918 mol/l
Class : Soluble
Log S (SILICOS-IT) : -1.36
Solubility : 7.33 mg/ml ; 0.0436 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 2.04

Safety of [ 139755-99-0 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P280 UN#:N/A
Hazard Statements:H302+H312+H332 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 139755-99-0 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 139755-99-0 ]
  • Downstream synthetic route of [ 139755-99-0 ]

[ 139755-99-0 ] Synthesis Path-Upstream   1~7

  • 1
  • [ 133261-07-1 ]
  • [ 139755-99-0 ]
YieldReaction ConditionsOperation in experiment
98% With hydrogenchloride In water at 100℃; The solution of I-03a (11 g, 56.12 mmol) in HCI (121 mL, 6 M) was heated to100 00 overnight. The reaction mixture was concentrated under vacuo and extracted with EA, washed with water and the organic layer was concentrated under vacuo to give I-04a (9.4 g, 98percent yield). ESI-MS (Mi-i): 169 calc. for 08H12N202: 168.1.
98% at 100℃; Preparation of intermediate l-04a: 1 -Methyl-3-propyl-1 /-/-pyrazole-5- carboxylic acid The solution of l-03a (1 1 g, 56.12 mmol) in HCI (121 mL, 6 M) was heated to 100 °C overnight. The reaction mixture was concentrated under vacuo and extracted with EA, washed with water and the organic layer was concentrated under vacuo to give l-04a (9.4 g, 98percent yield). ESI-MS (M+1 ): 169 calc. for C8H12N2O2: 168.1 .
96%
Stage #1: at 80℃; for 2 h;
Step 4
2-Methyl-5-propyl-2H-pyrazole-3-carboxylic acid:
2-methyl-5-propyl-2H-pyrazole-3-carboxylic acid ethyl ester (29.4 g, 150 mmol) was suspended in 6N sodium hydroxide (120 mL, 720 mmol) and heated to 80° C. for 2 hours, cooled, diluted with water (100 mL) and acidified with 5N hydrochloric acid (200 mL) to give a precipitate which was filtered off and dried to give the title compound as a white solid (24.2 g, 96percent).
1H NMR (300 MHz, CDCl3) δ 6.76 (s, 1H), 4.17 (s, 3H), 2.63 (t, 2H, J=7.2 Hz), 1.70-1.68 (m, 2H), 0.98 (t, 3H, J=7.2 Hz); LC-MS: m/z=169 (M+H)+;
90% at 75℃; for 3 h; Step 3: Synthesis of l-methyl-3-propyl-1H-pyrazole-5-carboxylic acid:-Ethyl 1-methyl-3-propyl-1H-pyrazole-5-carboxylate (19 gm 9.6 mini) was suspended in 6N NaOHsolution (48 ml 20.0 m.ml). The mixture was heated to 75 °C for 3 hours then cooled to 20 °C, diluted with 50 ml water and acidified with cone. HCI. Filtration gave the carboxylic acid as pale brown compound; Yield 90percent. 1H NMR (400 MHz, CDCI3) ö 9.15(br s 1H) 6.8 (s, 1H), 4.15(s, 3H) 2.50 (t, J7.6Hz 3H) 1.75 (m 2H) 0.98(tJ=7.6Hz3H). ppm. MASS: ESI [M + Na] : 191.09

Reference: [1] Patent: WO2014/131855, 2014, A1, . Location in patent: Page/Page column 80
[2] Patent: WO2016/20307, 2016, A1, . Location in patent: Page/Page column 50
[3] Patent: US2008/194529, 2008, A1, . Location in patent: Page/Page column 56-57
[4] Patent: WO2015/114647, 2015, A1, . Location in patent: Page/Page column 46; 47
[5] Patent: US5250534, 1993, A,
[6] Patent: US5272147, 1993, A,
[7] Patent: US6200980, 2001, B1,
[8] Patent: US6200980, 2001, B1,
[9] Bioorganic and Medicinal Chemistry Letters, 1996, vol. 6, # 15, p. 1819 - 1824
[10] Bioorganic and Medicinal Chemistry Letters, 2005, vol. 15, # 17, p. 3900 - 3907
[11] European Journal of Medicinal Chemistry, 2015, vol. 90, p. 889 - 896
  • 2
  • [ 36983-31-0 ]
  • [ 139755-99-0 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2005, vol. 15, # 17, p. 3900 - 3907
[2] Bioorganic and Medicinal Chemistry Letters, 1996, vol. 6, # 15, p. 1819 - 1824
[3] Patent: WO2014/131855, 2014, A1,
[4] Patent: WO2016/20307, 2016, A1,
  • 3
  • [ 92945-27-2 ]
  • [ 139755-99-0 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 1996, vol. 6, # 15, p. 1819 - 1824
[2] European Journal of Medicinal Chemistry, 2015, vol. 90, p. 889 - 896
[3] Patent: WO2015/114647, 2015, A1,
[4] Patent: WO2016/20307, 2016, A1,
  • 4
  • [ 107-87-9 ]
  • [ 139755-99-0 ]
Reference: [1] Journal of Heterocyclic Chemistry, 2001, vol. 38, # 5, p. 1045 - 1050
[2] Patent: WO2014/131855, 2014, A1,
[3] European Journal of Medicinal Chemistry, 2015, vol. 90, p. 889 - 896
[4] Patent: WO2016/20307, 2016, A1,
  • 5
  • [ 36983-31-0 ]
  • [ 60-34-4 ]
  • [ 139755-99-0 ]
  • [ 247583-70-6 ]
Reference: [1] Journal of Heterocyclic Chemistry, 2001, vol. 38, # 5, p. 1045 - 1050
  • 6
  • [ 139755-99-0 ]
  • [ 139756-02-8 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 1996, vol. 6, # 15, p. 1819 - 1824
[2] Bioorganic and Medicinal Chemistry Letters, 2005, vol. 15, # 17, p. 3900 - 3907
[3] Organic Process Research and Development, 2000, vol. 4, # 1, p. 17 - 22
[4] Patent: WO2014/131855, 2014, A1,
[5] European Journal of Medicinal Chemistry, 2015, vol. 90, p. 889 - 896
[6] Patent: WO2015/114647, 2015, A1,
[7] Patent: WO2016/20307, 2016, A1,
  • 7
  • [ 139755-99-0 ]
  • [ 139756-22-2 ]
Reference: [1] Patent: WO2014/131855, 2014, A1,
[2] Patent: WO2015/114647, 2015, A1,
[3] Patent: WO2016/20307, 2016, A1,
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 139755-99-0 ]

Carboxylic Acids

Chemical Structure| 26308-42-9

[ 26308-42-9 ]

3-Ethyl-1-methyl-1H-pyrazole-5-carboxylic acid

Similarity: 0.99

Chemical Structure| 5744-56-9

[ 5744-56-9 ]

1,3-Dimethyl-1H-pyrazole-5-carboxylic acid

Similarity: 0.94

Chemical Structure| 175277-11-9

[ 175277-11-9 ]

3-tert-Butyl-1-methylpyrazole-5-carboxylic Acid

Similarity: 0.93

Chemical Structure| 32275-62-0

[ 32275-62-0 ]

2-Ethyl-4,5,6,7-tetrahydro-2H-indazole-3-carboxylic acid

Similarity: 0.92

Chemical Structure| 50920-65-5

[ 50920-65-5 ]

1-Ethyl-3-methyl-1H-pyrazole-5-carboxylic acid

Similarity: 0.91

Related Parent Nucleus of
[ 139755-99-0 ]

Pyrazoles

Chemical Structure| 26308-42-9

[ 26308-42-9 ]

3-Ethyl-1-methyl-1H-pyrazole-5-carboxylic acid

Similarity: 0.99

Chemical Structure| 5744-56-9

[ 5744-56-9 ]

1,3-Dimethyl-1H-pyrazole-5-carboxylic acid

Similarity: 0.94

Chemical Structure| 175277-11-9

[ 175277-11-9 ]

3-tert-Butyl-1-methylpyrazole-5-carboxylic Acid

Similarity: 0.93

Chemical Structure| 50920-65-5

[ 50920-65-5 ]

1-Ethyl-3-methyl-1H-pyrazole-5-carboxylic acid

Similarity: 0.91

Chemical Structure| 10250-64-3

[ 10250-64-3 ]

1-Methyl-3-phenyl-1H-pyrazole-5-carboxylic acid

Similarity: 0.91